
Twist Bioscience Corporation TWST
$ 49.69
-6.16%
Quarterly report 2025-Q4
added 02-02-2026
Twist Bioscience Corporation Total Non Current Liabilities 2011-2026 | TWST
Annual Total Non Current Liabilities Twist Bioscience Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | 4.56 M | 299 M | 210 M | 144 M | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 299 M | 4.56 M | 164 M |
Total Non Current Liabilities of other stocks in the Diagnostics research industry
| Issuer | Total Non Current Liabilities | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Burning Rock Biotech Limited
BNR
|
61.1 M | $ 17.35 | -6.52 % | $ 183 M | ||
|
Centogene N.V.
CNTG
|
23.7 M | - | -6.23 % | $ 30.6 M | ||
|
Co-Diagnostics
CODX
|
574 K | $ 1.46 | -10.44 % | $ 1.94 M | ||
|
Castle Biosciences
CSTL
|
2.76 M | $ 19.26 | 1.99 % | $ 558 M | ||
|
Fulgent Genetics
FLGT
|
2.26 M | $ 16.02 | -1.05 % | $ 484 M | ||
|
Agilent Technologies
A
|
3.29 B | $ 112.14 | -0.98 % | $ 34.1 B | ||
|
Akumin
AKU
|
527 M | - | -17.87 % | $ 25.9 M | ||
|
Aspira Women's Health
AWH
|
3.49 M | - | -6.19 % | $ 10.5 M | ||
|
Accelerate Diagnostics
AXDX
|
134 M | - | -61.36 % | $ 2.46 M | ||
|
Illumina
ILMN
|
2.04 B | $ 140.19 | -2.13 % | $ 22.3 B | ||
|
Biocept
BIOC
|
11.3 M | - | -13.05 % | $ 7.29 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
7.74 M | - | - | $ 562 M | ||
|
Interpace Biosciences
IDXG
|
10 M | $ 1.8 | -5.26 % | $ 7.96 M | ||
|
CareDx, Inc
CDNA
|
17.9 M | $ 20.04 | -2.22 % | $ 1.07 B | ||
|
Chembio Diagnostics
CEMI
|
24.8 M | - | 0.22 % | $ 16.8 M | ||
|
Lantheus Holdings
LNTH
|
225 M | $ 94.57 | -2.18 % | $ 6.38 B | ||
|
Check-Cap Ltd.
CHEK
|
16 K | - | - | $ 9.42 M | ||
|
HTG Molecular Diagnostics
HTGM
|
4.1 M | - | -20.0 % | $ 1.06 M | ||
|
Medpace Holdings
MEDP
|
73.8 M | $ 420.05 | 0.21 % | $ 12.1 B | ||
|
Mettler-Toledo International
MTD
|
1.61 B | $ 1 048.98 | 0.68 % | $ 21.6 B | ||
|
Myriad Genetics
MYGN
|
107 M | $ 3.62 | - | $ 335 M | ||
|
Global Cord Blood Corporation
CO
|
2.53 B | - | - | $ 399 M | ||
|
NeoGenomics
NEO
|
435 M | $ 8.3 | -0.72 % | $ 1.06 B | ||
|
Fluidigm Corporation
FLDM
|
131 M | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
559 K | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
48.5 M | - | 0.12 % | $ 80.1 M | ||
|
DermTech
DMTK
|
865 K | - | -11.32 % | $ 2.94 M | ||
|
Charles River Laboratories International
CRL
|
2.35 B | $ 158.51 | -0.5 % | $ 7.86 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
1.43 B | - | - | $ 10.7 B | ||
|
National Research Corporation
NRC
|
39.6 M | $ 19.0 | 0.37 % | $ 425 M | ||
|
Natera
NTRA
|
124 M | $ 185.77 | -5.66 % | $ 18.3 B | ||
|
Enzo Biochem
ENZ
|
4.6 M | - | -8.98 % | $ 14.8 K | ||
|
Koninklijke Philips N.V.
PHG
|
8.45 B | $ 25.23 | -1.1 % | $ 23.9 B | ||
|
Exact Sciences Corporation
EXAS
|
981 M | - | - | $ 19.8 B | ||
|
Senseonics Holdings
SENS
|
163 M | $ 5.84 | 0.34 % | $ 244 M | ||
|
Guardant Health
GH
|
91.4 M | $ 95.26 | -3.45 % | $ 11.9 B | ||
|
Personalis
PSNL
|
639 K | $ 6.46 | -3.73 % | $ 576 M | ||
|
Heska Corporation
HSKA
|
57.9 M | - | - | $ 1.31 B | ||
|
ICON Public Limited Company
ICLR
|
461 M | $ 118.21 | 0.96 % | $ 9.75 B | ||
|
Soleno Therapeutics
SLNO
|
10.8 M | $ 52.99 | -0.01 % | $ 2.69 B | ||
|
QIAGEN N.V.
QGEN
|
1.99 B | - | - | $ 10.6 B | ||
|
Biomerica
BMRA
|
1.57 M | $ 2.31 | -4.04 % | $ 5.31 M | ||
|
Laboratory Corporation of America Holdings
LH
|
7.82 B | $ 251.84 | -0.89 % | $ 21 B | ||
|
Thermo Fisher Scientific
TMO
|
22.5 B | $ 441.44 | -1.5 % | $ 166 B | ||
|
Trinity Biotech plc
TRIB
|
106 M | $ 0.59 | 1.42 % | $ 212 M | ||
|
Celcuity
CELC
|
69.2 K | $ 132.6 | -1.57 % | $ 6.2 B | ||
|
Motus GI Holdings
MOTS
|
2.16 M | - | -34.28 % | $ 263 K | ||
|
Waters Corporation
WAT
|
1.28 B | $ 332.1 | -0.33 % | $ 19.8 B | ||
|
Neogen Corporation
NEOG
|
19.6 M | $ 8.36 | -0.83 % | $ 1.81 B |